Search Results - "Weber, Irene T"
-
1
Beyond darunavir: recent development of next generation HIV-1 protease inhibitors to combat drug resistance
Published in Chemical communications (Cambridge, England) (20-10-2022)“…We report our recent development of a conceptually new generation of exceptionally potent non-peptidic HIV-1 protease inhibitors that displayed excellent…”
Get more information
Journal Article -
2
Machine learning methods accurately predict host specificity of coronaviruses based on spike sequences alone
Published in Biochemical and biophysical research communications (10-12-2020)“…Coronaviruses infect many animals, including humans, due to interspecies transmission. Three of the known human coronaviruses: MERS, SARS-CoV-1, and…”
Get full text
Journal Article -
3
HIV Protease: Historical Perspective and Current Research
Published in Viruses (06-05-2021)“…The retroviral protease of human immunodeficiency virus (HIV) is an excellent target for antiviral inhibitors for treating HIV/AIDS. Despite the efficacy of…”
Get full text
Journal Article -
4
Evolution of drug resistance in HIV protease
Published in BMC bioinformatics (30-12-2020)“…Drug resistance is a critical problem limiting effective antiviral therapy for HIV/AIDS. Computational techniques for predicting drug resistance profiles from…”
Get full text
Journal Article -
5
Enhancing Protein Backbone Binding-A Fruitful Concept for Combating Drug-Resistant HIV
Published in Angewandte Chemie International Edition (20-02-2012)“…The evolution of drug resistance is one of the most fundamental problems in medicine. In HIV/AIDS, the rapid emergence of drug‐resistant HIV‐1 variants is a…”
Get full text
Journal Article -
6
Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics
Published in PloS one (16-12-2016)“…We report structural analysis of HIV protease variant PRS17 which was rationally selected by machine learning to represent wide classes of highly…”
Get full text
Journal Article -
7
Structure-Based Design of Highly Potent HIV‑1 Protease Inhibitors Containing New Tricyclic Ring P2-Ligands: Design, Synthesis, Biological, and X‑ray Structural Studies
Published in Journal of medicinal chemistry (14-05-2020)“…We describe here design, synthesis, and biological evaluation of a series of highly potent HIV-1 protease inhibitors containing stereochemically defined and…”
Get full text
Journal Article -
8
Discovery of a new flavin N5-adduct in a tyrosine to phenylalanine variant of d-Arginine dehydrogenase
Published in Archives of biochemistry and biophysics (15-01-2022)“…d-Arginine dehydrogenase from Pseudomonas aeruginosa (PaDADH) catalyzes the flavin-dependent oxidation of d-arginine and other d-amino acids. Here, we report…”
Get full text
Journal Article -
9
Design of HIV Protease Inhibitors Targeting Protein Backbone: An Effective Strategy for Combating Drug Resistance
Published in Accounts of chemical research (01-01-2008)“…The discovery of human immunodeficiency virus (HIV) protease inhibitors (PIs) and their utilization in highly active antiretroviral therapy (HAART) have been a…”
Get full text
Journal Article -
10
Potent antiviral HIV-1 protease inhibitor combats highly drug resistant mutant PR20
Published in Biochemical and biophysical research communications (29-10-2019)“…Drug-resistance threatens effective treatment of HIV/AIDS. Clinical inhibitors, including darunavir (1), are ineffective for highly resistant protease mutant…”
Get full text
Journal Article -
11
Evaluation of darunavir-derived HIV-1 protease inhibitors incorporating P2′ amide-derivatives: Synthesis, biological evaluation and structural studies
Published in Bioorganic & medicinal chemistry letters (01-03-2023)“…[Display omitted] We report here the synthesis and biological evaluation of darunavir derived HIV-1 protease inhibitors and their functional effect on enzyme…”
Get full text
Journal Article -
12
Analysis of drug resistance in HIV protease
Published in BMC bioinformatics (22-10-2018)“…Drug resistance in HIV is the major problem limiting effective antiviral therapy. Computational techniques for predicting drug resistance profiles from genomic…”
Get full text
Journal Article -
13
Design and Synthesis of Potent HIV‑1 Protease Inhibitors Containing Bicyclic Oxazolidinone Scaffold as the P2 Ligands: Structure–Activity Studies and Biological and X‑ray Structural Studies
Published in Journal of medicinal chemistry (08-11-2018)“…We have designed, synthesized, and evaluated a new class of potent HIV-1 protease inhibitors with novel bicyclic oxazolidinone derivatives as the P2 ligand. We…”
Get full text
Journal Article -
14
Automated prediction of HIV drug resistance from genotype data
Published in BMC bioinformatics (31-08-2016)“…HIV/AIDS is a serious threat to public health. The emergence of drug resistance mutations diminishes the effectiveness of drug therapy for HIV/AIDS. Developing…”
Get full text
Journal Article -
15
HIV-1 Protease: Structural Perspectives on Drug Resistance
Published in Viruses (01-12-2009)“…Antiviral inhibitors of HIV-1 protease are a notable success of structure-based drug design and have dramatically improved AIDS therapy. Analysis of the…”
Get full text
Journal Article Book Review -
16
Room Temperature Neutron Crystallography of Drug Resistant HIV‑1 Protease Uncovers Limitations of X‑ray Structural Analysis at 100 K
Published in Journal of medicinal chemistry (09-03-2017)“…HIV-1 protease inhibitors are crucial for treatment of HIV-1/AIDS, but their effectiveness is thwarted by rapid emergence of drug resistance. To better…”
Get full text
Journal Article -
17
Long-Range Electrostatics-Induced Two-Proton Transfer Captured by Neutron Crystallography in an Enzyme Catalytic Site
Published in Angewandte Chemie (International ed.) (11-04-2016)“…Neutron crystallography was used to directly locate two protons before and after a pH‐induced two‐proton transfer between catalytic aspartic acid residues and…”
Get full text
Journal Article -
18
Inhibition of autoprocessing of natural variants and multidrug resistant mutant precursors of HIV-1 protease by clinical inhibitors
Published in Proceedings of the National Academy of Sciences - PNAS (31-05-2011)“…Self-cleavage at the N terminus of HIV-1 protease from the Gag-Pol precursor (autoprocessing) is crucial for stabilizing the protease dimer required for onset…”
Get full text
Journal Article -
19
Potent HIV‐1 Protease Inhibitors Containing Carboxylic and Boronic Acids: Effect on Enzyme Inhibition and Antiviral Activity and Protein‐Ligand X‐ray Structural Studies
Published in ChemMedChem (06-11-2019)“…We report the synthesis and biological evaluation of phenylcarboxylic acid and phenylboronic acid containing HIV‐1 protease inhibitors and their functional…”
Get full text
Journal Article -
20
Design, Synthesis and X‐Ray Structural Studies of Potent HIV‐1 Protease Inhibitors Containing C‐4 Substituted Tricyclic Hexahydro‐Furofuran Derivatives as P2 Ligands
Published in ChemMedChem (04-05-2022)“…The design, synthesis, X‐ray structural, and biological evaluation of a series of highly potent HIV‐1 protease inhibitors are reported herein. These inhibitors…”
Get full text
Journal Article